ARTIVA BIOTHERAPEUTICS INC. - COMMON STOCK
1.9800
03-June-25 07:22:48
15 minutes delayed
Stocks
+0.0400
+2.06%
Today's range
1.8900 - 1.9800
ISIN
N/A
Source
NASDAQ
-
Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference
28 May 2025 13:05:00 By Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights
08 May 2025 05:00:00 By Nasdaq GlobeNewswire
-
28 Apr 2025 13:35:00 By Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer
08 Apr 2025 13:05:00 By Nasdaq GlobeNewswire
-
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
31 Mar 2025 13:05:00 By Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
24 Mar 2025 13:05:00 By Nasdaq GlobeNewswire
-
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
20 Feb 2025 13:05:00 By Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.
29 Jan 2025 13:05:00 By Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
12 Nov 2024 13:05:01 By Nasdaq GlobeNewswire
-
Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference
11 Nov 2024 13:05:00 By Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
22 Oct 2024 13:05:00 By Nasdaq GlobeNewswire
-
Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
10 Sep 2024 13:05:00 By Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
29 Aug 2024 13:05:00 By Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
18 Jul 2024 16:08:52 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >